Medication Synchronization Programs Improve Adherence To Cardiovascular Medications And Health Care Use.

Medication synchronization programs based in pharmacies simplify the refill process by enabling patients to pick up all of their medications on a single visit. This can be especially important for improving medication adherence in patients with complex chronic diseases. We evaluated the impact of two synchronization programs on adherence, cardiovascular events, and resource use among Medicare beneficiaries treated between 2011 and 2014 for two or more chronic conditions-at least one of which was hypertension, hyperlipidemia, or diabetes. Among nearly 23,000 patients matched by propensity score, the mean proportion of days covered (a measure of medication adherence) for the control group of patients without a synchronization program was 0.84 compared to 0.87 for synchronized patients-a gain of 3 percentage points. Adherence improvement in synchronized versus control patients was three times greater in patients with low baseline adherence, compared to those with higher baseline adherence. Rates of hospitalization and emergency department visits and rates of outpatient visits were 9 percent and 3 percent lower in the synchronized group compared to the control group, respectively, while cardiovascular event rates were similar. Synchronization programs were associated with improved adherence for patients with cardiovascular disease, especially those with low baseline adherence.

[1]  T. Brennan,et al.  Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study. , 2017, Journal of managed care & specialty pharmacy.

[2]  D. Blackburn,et al.  Evaluation of a refill synchronization program in two community pharmacies. , 2016, Journal of the American Pharmacists Association : JAPhA.

[3]  D. Holdford,et al.  Cost-benefit of appointment-based medication synchronization in community pharmacies. , 2016, The American journal of managed care.

[4]  K. Volpp,et al.  A Synchronized Prescription Refill Program Improved Medication Adherence. , 2016, Health affairs.

[5]  N. Choudhry,et al.  Prevalence, effectiveness, and characteristics of pharmacy-based medication synchronization programs. , 2016, The American journal of managed care.

[6]  T. Brennan,et al.  Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes , 2014, Annals of Internal Medicine.

[7]  J. May,et al.  Examining the Effect of a Medication Synchronization or an Education Program on Health Outcomes of Hypertensive Patients in a Community Pharmacy Setting , 2014 .

[8]  D. Holdford,et al.  Adherence and persistence associated with an appointment-based medication synchronization program. , 2013, Journal of the American Pharmacists Association : JAPhA.

[9]  Sebastian Schneeweiss,et al.  The impact of reducing cardiovascular medication copayments on health spending and resource utilization. , 2012, Journal of the American College of Cardiology.

[10]  Lonny Reisman,et al.  Full coverage for preventive medications after myocardial infarction. , 2011, The New England journal of medicine.

[11]  Sebastian Schneeweiss,et al.  A combined comorbidity score predicted mortality in elderly patients better than existing scores. , 2011, Journal of clinical epidemiology.

[12]  Sebastian Schneeweiss,et al.  The implications of therapeutic complexity on adherence to cardiovascular medications. , 2011, Archives of internal medicine.

[13]  Sarah L Cutrona,et al.  Modes of delivery for interventions to improve cardiovascular medication adherence. , 2010, The American journal of managed care.

[14]  Julie A Schmittdiel,et al.  Mail-order pharmacy use and adherence to diabetes-related medications. , 2010, The American journal of managed care.

[15]  James M Wright,et al.  Statin Adherence and Risk of Accidents: A Cautionary Tale , 2009, Circulation.

[16]  J. Schwartz,et al.  Does Synchronizing Initiation of Therapy Affect Adherence to Concomitant Use of Antihypertensive and Lipid-Lowering Therapy? , 2009, American journal of therapeutics.

[17]  Bradley C Martin,et al.  An Empirical Basis for Standardizing Adherence Measures Derived From Administrative Claims Data Among Diabetic Patients , 2008, Medical care.

[18]  J. Avorn,et al.  Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. , 2007, American journal of epidemiology.

[19]  John Hsu,et al.  Unintended consequences of caps on Medicare drug benefits. , 2006, The New England journal of medicine.

[20]  B. Motheral,et al.  Randomized Controlled Trial of a Dose Consolidation Program , 2004, Journal of managed care pharmacy : JMCP.

[21]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[22]  E. Braunwald,et al.  Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction. , 1997, The American journal of cardiology.